Literature DB >> 20624039

Vaccines as physically and chemically well-defined pharmaceutical dosage forms.

David B Volkin, C Russell Middaugh.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20624039     DOI： 10.1586/erv.10.73

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  5 in total

1.  Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge.

Authors:  Yuhong Xiao; Yuhong Zeng; Edward Alexander; Shyam Mehta; Sangeeta B Joshi; George W Buchman; David B Volkin; C Russell Middaugh; Stuart N Isaacs
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

2.  Protein antigen adsorption to the DDA/TDB liposomal adjuvant: effect on protein structure, stability, and liposome physicochemical characteristics.

Authors:  Mette Hamborg; Lene Jorgensen; Anders Riber Bojsen; Dennis Christensen; Camilla Foged
Journal:  Pharm Res       Date:  2012-09-06       Impact factor: 4.200

3.  Detection and characterization of subvisible aggregates of monoclonal IgG in serum.

Authors:  Vasco Filipe; Robert Poole; Olubukayo Oladunjoye; Kevin Braeckmans; Wim Jiskoot
Journal:  Pharm Res       Date:  2012-03-31       Impact factor: 4.200

4.  Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine.

Authors:  Sanjeev Agarwal; Neha Sahni; John M Hickey; George A Robertson; Robert Sitrin; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-08-07       Impact factor: 3.534

5.  Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.

Authors:  Sanjeev Agarwal; John M Hickey; Neha Sahni; Ronald T Toth; George A Robertson; Robert Sitrin; Stanley Cryz; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2019-08-07       Impact factor: 3.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.